BetterLife Pharma Inc. Share Price Börse Stuttgart
Equities
NPAU
CA08772P2026
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0805 EUR | +4.55% | +8.78% | +126.76% |
05-14 | BetterLife Obtains Excellent Animal Cardiopulmonary Safety Data for Oral BETR-001 | CI |
05-03 | BetterLife Pharma Inc. announced that it expects to receive CAD 0.5 million in funding | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 13.32M 12.28M 1.05B |
---|---|---|---|---|---|
Net income 2022 | -12M -11.07M -942M | Net income 2023 | -9M -8.3M -706M | EV / Sales 2022 | - |
Net Debt 2022 | 139K 128K 10.9M | Net Debt 2023 | 71.69K 66.11K 5.63M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.26
x | P/E ratio 2023 |
-1.36
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 73.4% |
1 week | +8.78% | ||
Current month | +12.59% | ||
1 month | +12.59% | ||
3 months | +49.07% | ||
6 months | +126.76% | ||
Current year | +126.76% |
Managers | Title | Age | Since |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 16/09/07 |
Moira Ong
DFI | Director of Finance/CFO | 49 | 25/12/10 |
Chief Operating Officer | 67 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 16/09/07 |
Robert Metcalfe
BRD | Director/Board Member | 84 | 20/01/20 |
Wolfgang Renz
BRD | Director/Board Member | 54 | 04/02/15 |
Date | Price | Change |
---|---|---|
31/05/24 | 0.0805 | +4.55% |
30/05/24 | 0.077 | +4.05% |
29/05/24 | 0.074 | -.--% |
28/05/24 | 0.074 | -3.90% |
27/05/24 | 0.077 | +4.05% |
Delayed Quote Börse Stuttgart, May 31, 2024 at 02:32 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- BETRF Stock
- NPAU Stock